Related by context. All words. (Click for frequent words.) 74 kidney urologic 72 Additional BiTE antibodies 72 oral kinase inhibitor 72 RAS MAPK pathway 72 ribonucleotide reductase clinically validated 72 CEA CD# Her2 71 Alzheimer disease cognitive impairment 71 Systemic lupus erythematosus SLE 70 ischemic tissues 70 M2 subunit 70 investigational therapies 70 CYT# potent vascular disrupting 70 humanised antibody designed 70 demonstrated anti amnesic 70 Ischemic Spastic Paraplegia Traumatic 70 Enzastaurin 70 GRNOPC1 contains 70 ORTHOVISC ® mini 69 CCR9 antagonist 69 accumulate preferentially 69 cardiovascular restenosis cancer 68 cardio metabolic diseases 68 C1 INH deficiency 68 OncoVex 68 follicular Non Hodgkin 68 Treatment Shows Promise 68 thetreatment 68 Podtrac survey 68 metastatic colorectal 68 humanized therapeutic 68 protein kinase inhibitor 68 ZACTIMA TM ZD# 67 colorectal bladder 67 multiple sclerosis psoriasis 67 Multiple Sclerosis Rheumatoid Arthritis 67 gastrointestinal stromal 67 membranous nephritis 67 deCODE AF TM 67 targeting miR 67 DG# compounds targeting 67 psoriasis rheumatoid arthritis 67 leukemia myeloma 67 multiple sclerosis rheumatoid arthritis 67 diseases osteoarthritis osteoporosis 67 taxane derivative 67 Slows Progression 67 treat relapsing forms 67 targeted immunotherapies 67 Provectus Pharmaceuticals specializes 67 Ampakine compounds 67 modulate ion channel 66 antisense therapies 66 experimental autoimmune encephalomyelitis 66 alpha folate receptor 66 PLX STROKE targeting 66 location Siskovic 66 Naive Patients 66 Actress Annette Funicello 66 LymphoStat B belimumab 66 Vandetanib 66 deCODE ProstateCancer TM 66 inflammatory demyelinating 66 Traumatic Spinal Cord Injury 66 Drug Shows Promise 66 Shows Promise Against 66 novel VDA molecule 66 treating neuropathic pain 66 #:#-#,# CrossRef Medline [001] 66 debilitating autoimmune 66 neuropathic pain spasticity 66 hereditary emphysema 66 progressive demyelinating disease 66 Ribavirin causes 66 gastro intestinal inflammation 66 identify protein biomarkers 66 Pertuzumab 66 include Ischemic Paraplegia 66 lupus multiple sclerosis 66 Archexin 66 CTAP# Capsules 66 interferon alpha IFN 66 Cobalamin TM mediated 66 #I TM# 66 specific chemokine receptors 66 receptor tyrosine kinase inhibitor 66 MCSP respectively 66 Darapladib 66 triggers apoptosis programmed 66 mTOR kinase 66 IAP inhibitor 66 NS5b 65 fusion enhancers 65 INSPIRE Trial Phase III 65 specific lectin receptors 65 delay bone metastases 65 5 HT4 65 Platinum Resistant Ovarian 65 monoclonal antibody MAb 65 MEK ERK 65 Daclizumab 65 FUSILEV enhances 65 MAGE A3 ASCI 65 Interferon beta 65 Prednisone Against Refractory 65 Imatinib mesylate 65 Anthracycline 65 multiple sclerosis Crohn disease 65 Genes Identified 65 Smac mimetics 65 insomnia migraine headaches 65 recurrent glioblastoma multiforme 65 Temsirolimus 65 peptibody 65 INS# [001] 65 basal cell carcinoma squamous 65 rheumatoid arthritis osteoarthritis ankylosing 65 class mGluR5 inhibitor 65 AAG geldanamycin analog 65 immunotherapeutic approaches 65 HepDirect technology 65 M# rationally 65 epilepsy Parkinson disease 65 hormonally sensitive 65 IMiDs 65 immunocompetent adults 65 Protein Kinase C 65 Elotuzumab 65 pancreatic islet beta 65 neurodegenerative diseases Alzheimer disease 65 systemic autoimmune 65 deCODE Glaucoma TM 65 mertansine 65 Acute myelogenous leukemia 65 HuLuc# 65 POTELLIGENT ® Technology 65 oral immunomodulatory 65 leukemia lymphoma multiple myeloma 65 selectively inhibit replication 65 signal transduction inhibitors 65 AVAX AC Vaccine 64 Sapacitabine 64 Relapsing remitting 64 secretory diarrhea 64 progressive neurodegenerative 64 solid tumors ZYBRESTAT 64 secretory phospholipase A2 64 Denufosol 64 novel therapeutic antibodies 64 Oral Laquinimod 64 IMiDs R 64 misfolded SOD1 64 Oral Fingolimod 64 anti amnesic 64 Squamous Cell 64 NASH Huntington 64 Tesmilifene 64 treat musculoskeletal metabolic 64 Kinoid 64 Monoclonal antibody 64 Otelixizumab 64 JAK#/JAK# inhibitor CYT# 64 ENMD # 64 Gene Mutation Linked 64 Virulizin ® 64 Rigel R# 64 CYP#A# substrate 64 hypervascular tumors 64 pathological hallmark 64 Cholesterol lowering statins 64 BEMA TM Buprenorphine 64 RhuDex ™ 64 Acute Intermittent Porphyria 64 IMiDs ® 64 Ep CAM 64 Lisofylline 64 VitiGam 64 TTR amyloidosis 64 c Raf kinase 64 rotavirus shingles 64 hormone gastrin 64 beta emitting radioisotope 64 TNF Blockers 64 attach auristatin 64 sapacitabine CYC# 64 0 SHOTS OFF 64 Combivir Kivexa 64 formerly LymphoStat B 64 hematological malignancy 64 Gleevec resistant 64 ZACTIMA 64 leukotriene pathway 64 CD# expressing 64 dimebon latrepirdine 64 Leukemias 64 Panzem 64 osteoporosis osteoarthritis 64 galiximab 64 anticancer therapeutics 64 vascular occlusive diseases 64 metastatic renal 64 NEUGENE antisense compound 64 rheumatoid arthritis juvenile idiopathic 64 neuroinflammatory 64 immune modulating 64 refractory metastatic 64 chronic degenerative neurological 64 rheumatoid arthritis psoriasis 64 protein receptors lectins 64 neurodegenerative disorder characterized 64 humanized interleukin 6 64 Epidermal Growth Factor Receptor 64 Genes Discovered 64 pancreas esophagus 64 4 PDE4 enzyme 64 Talabostat 64 opioid naive 64 Degarelix 64 Rilonacept 64 oncolytic virus therapies 64 including HGF ErbB3 64 TRIOLEX HE# APOPTONE HE# 64 Cogane 64 psoriasis Crohn disease 64 SNT MC# 64 Golimumab 63 myeloproliferative neoplasms MPNs 63 VANTAS ® 63 Immunotherapeutic 63 mGluR2 NAM 63 protein tyrosine phosphatase 1B 63 sirtuin inhibitor program 63 treat chronic rhinosinusitis 63 dermatologic diseases 63 HIV AIDS neuropathic pain 63 R Saizen R 63 intravenous CK # 63 included exfoliative dermatitis 63 SYN# 63 FDA Approves Novel 63 Company TAIFUN R 63 injury ischemic spastic 63 PI3K/mTOR 63 Combination REOLYSIN R 63 GRN# 63 metastatic carcinoid 63 neurovascular diseases 63 humanised monoclonal antibody 63 intravesical infusion therapy 63 progressive degenerative neurological 63 regorafenib 63 Ph + acute lymphoblastic 63 Research www. elsevier.com 63 neuroendocrine cancers 63 dasatinib Sprycel 63 CYP#A# CYP#D# 63 Blinatumomab 63 psoriasis inflammatory bowel 63 aflibercept VEGF Trap 63 HCV polymerase 63 Clot Busting 63 Cell Non Hodgkin 63 inhibit metastasis 63 radiolabeled TM# 63 Inhaled nitric oxide 63 trastuzumab Herceptin ® 63 HQK 63 Natalizumab 63 biologic antibody 63 Amgen Neulasta R 63 relapsing remitting MS RRMS 63 Eculizumab 63 Lymphocytic 63 chemically modified siRNA 63 PF # [002] 63 alpha#beta# 63 EGFR pathway 63 diabetic kidney 63 Cytotoxic T 63 Aflibercept 63 PDE# 63 relapsed MM 63 Ocrelizumab 63 Evoltra ® 63 Belimumab 63 Vaccine Shows Promise 63 Glioblastoma multiforme GBM 63 muscular dystrophy cystic fibrosis 63 adalimumab Humira 63 recurrent metastatic ovarian cancer 63 Budesonide foam crofelemer 63 pralatrexate injection folate analogue 63 TRAIL induced apoptosis 63 targeted kinase inhibitor 63 metastatic neuroendocrine tumors 63 A3 adenosine receptor 63 AFREZZA TM 63 Tramiprosate ALZHEMED TM 63 purinergic receptors P#X# 63 MKC# MT 63 investigational monoclonal antibody 63 thromboxane A2 63 selective angiogenic kinase inhibitor 63 Imetelstat 63 inhibit replication 63 recombinant PSMA vaccine 63 samalizumab 63 neovascular diseases 63 pancreatic prostate 63 prostate cancer antigen prostatic 63 Azixa MPC 63 refractory Hodgkin 63 IMA# 63 mTOR mammalian target 63 reduce serum phosphate 63 either acutely decompensated 63 unresectable tumors 63 Mg Usa 63 purified inactivated vaccine 63 Alemtuzumab 63 Acute myeloid leukemia 63 Aeolus Pharmaceuticals Announces 63 adhesion molecule EpCAM expressing 63 essential thrombocythemia ET 63 myocardial infarction ventricular fibrillation 63 sorafenib tablets 63 cathepsins 63 Adrenomyeloneuropathy AMN 63 chronic myeloid 63 Clostridium Difficile Associated 63 castrate resistant prostate cancer 63 MitoQ 63 rheumatoid arthritis inflammatory bowel 63 immunologic diseases 63 LHRH receptor positive 63 angina nausea 63 myelofibrosis polycythemia vera 63 cyclophosphamide chemotherapy 63 NS5B polymerase 63 rheumatoid arthritis psoriatic arthritis 63 inhibits blood clotting 63 oral prodrug 63 Aflibercept VEGF Trap 63 Malignant Glioma 63 AA Amyloidosis 63 pathophysiological effects 63 protein kinase inhibitors 63 Shark cartilage 63 GVAX Immunotherapy 63 investigational immunotherapy 63 antiangiogenesis therapies 63 FBPase 63 chronic progressive neurodegenerative 63 CD# antibody [002] 63 Nanobody 63 ErbB3 HER3 63 systemic RNA interference 63 molecules Immune SIMULATORS 63 PROCHYMAL 63 Sudhir Agrawal D.Phil 63 Deforolimus 63 Carcinoid tumors 63 AKT inhibitor 63 acute porphyria 63 metaglidasen 63 trial evaluating PRX# 63 RhuDex R 62 K ras mutations 62 IMiDs ® compound 62 autoimmune encephalitis 62 biomarkers predictive 62 commercializing novel biotherapeutics 62 naloxol derivative 62 aldehyde dehydrogenase ALDH2 deficiency 62 related CMV Retinitis 62 BRAF kinase 62 multi kinase inhibitor 62 PR interval prolongation 62 aMCI precursor 62 IGF IR 62 budesonide foam 62 targeted antifolate 62 Acute leukemia 62 inflammatory PDE 62 psoriatic arthritis PsA 62 antibody mediated 62 potent antiproliferative 62 plasma kallikrein inhibitor 62 Acute Exacerbations 62 Factor Receptor 62 cosmetic cosmeceutical products 62 adrenergic regulation 62 diagnostic molecular imaging 62 Umbilical cord stem cells 62 PSMA ADC 62 candidates Azedra TM 62 telomerase inhibitor 62 HGS ETR1 mapatumumab 62 molecular abnormalities 62 forodesine 62 D aspartate NMDA receptor 62 Vicinium TM 62 Prodarsan R 62 immunodeficiency disorders 62 systemic RNAi therapeutic 62 leukemia multiple myeloma 62 Delta opioid receptor 62 Array BioPharma Reports 62 Epratuzumab 62 non hodgkin lymphoma 62 ALN TTR 62 Hypertensive adverse reactions 62 p# MAP kinase 62 Albuferon albinterferon alfa 2b 62 asthma rheumatoid arthritis 62 mda 7 62 BHT DNA 62 visilizumab 62 chemokine receptor 62 Nonalcoholic fatty liver 62 Angiograms carry slight 62 LSE ASM 62 gastrointestinal stromal tumors GISTs 62 ImmunoGen TAP technology 62 Protease inhibitors 62 Genetic mutation 62 alpha 2A adrenergic 62 Notch receptors 62 Discoveries Tomorrow 62 Parkinson disease multiple sclerosis 62 Granulocyte Colony Stimulating Factor 62 tramiprosate Alzhemed TM 62 5 HT2A inverse 62 Physician Insights 62 PDE4 modulators 62 receiving chemoradiation therapy 62 Romidepsin 62 lymphoma leukemia 62 CIMZIA r certolizumab pegol 62 biomarker identification 62 platform HDL Mimetic 62 MAbs targeting 62 chimeric monoclonal antibody 62 Magnesium deficiency 62 common neurovascular complication 62 dasatinib Sprycel ® 62 lymphoma multiple myeloma 62 Crizotinib 62 constipation OIC 62 transthyretin TTR 62 Vidofludimus 62 cMET 62 hyperphenylalaninemia HPA due 62 Anti VEGF 62 oral ghrelin agonist 62 including eniluracil ADH 62 Hepatocellular Carcinoma HCC 62 Teriflunomide 62 R sorafenib tablets 62 tubulin inhibitor 62 Glioblastoma multiforme 62 Smac mimetic 62 anticancer antiviral 62 CDK cyclin dependent 62 breast endometrial 62 inhibit EGFR 62 engineered RAP peptides 62 Zorbtive TM 62 delta isoform 62 PORxin TM platforms 62 alemtuzumab Campath 62 inherited neurodegenerative 62 AIDS prophylaxis congestive 62 metabotropic glutamate receptors 62 Etanercept 62 EOquin TM phase 62 Cerebral palsy involves 62 dirucotide MBP# 62 Detrol Detrol LA 62 chronic granulomatous disease 62 Myelofibrosis 62 ZFP Therapeutics 62 dihydrofolate reductase DHFR 62 castration resistant hormone refractory 62 common disabling neurological 62 Antitumor Activity 62 novel immunotherapies 62 lung pancreatic 62 Alzheimer Disease Parkinson Disease 62 acadesine 62 Locked Nucleic Acid LNA 62 ® natalizumab 62 CYP#A# isoenzyme 62 PI3K Akt 62 Bayer HealthCare Onyx Pharmaceuticals 62 Protein Linked 62 GI motility disorders 62 selectively inhibited 62 vaginal candidiasis 62 rheumatic disorders 62 proteasome inhibitor 62 histone deacetylase HDAC inhibitors 62 glucagon receptor 62 Glioma 62 Progressive Multifocal Leukoencephalopathy 62 LHRH antagonists 62 alvespimycin 62 neuro inflammatory 62 pertuzumab 62 humanized monoclonal antibodies 62 Polyneuropathy 62 Myasthenia gravis 62 GW# [003] 62 agonistic human 62 Balamuthia 62 advanced medullary thyroid 62 BRAF inhibitor 62 Brussels THR 62 metastatic bladder 62 Asthma COPD 62 Maintain Overweight rating 62 Nanobodies ® 62 GVAX ® 62 cytidine nucleoside analog 62 Duchenne Becker 62 rapamycin kinase 62 Macular edema 62 gefitinib Iressa 62 interferon alpha IFN alpha 62 thymidylate synthase 62 Pruvel TM 62 RhuDex TM 62 pharmacogenomic translational research 62 Amgen Neulasta ® 62 novel chimeric natriuretic 62 THR beta agonist 62 Nasdaq IMGN biotechnology 62 Darinaparsin 62 GVAX Pancreas Vaccine 62 DAC HYP 62 dyslipidemia hypertension diabetes 62 delta gamma agonist 61 sarcoma melanoma 61 Alzheimer disease frontotemporal dementia 61 Carbidopa 61 testing huN# DM1 61 develop HBV reactivation 61 severe hepatic dysfunction 61 oligodendrogliomas 61 rheumatoid arthritis multiple sclerosis 61 Drug Prevents 61 Anti psychotics 61 Safinamide 61 VitiGam TM 61 ovarian endometrial 61 Exherin TM 61 certain protein tyrosine 61 sunitinib Sutent ® 61 Achieves Primary Endpoint 61 Relapsed Refractory 61 Janus kinase 61 Chronic Myelogenous Leukemia CML 61 PNP inhibitor 61 Chronic pancreatitis 61 antimitotic 61 CFTR corrector 61 XOMA 3AB biodefense 61 Mg Uk 61 PDE# inhibitors 61 Randomized Double blind 61 p# inhibitor 61 Fingolimod 61 multitargeted 61 CEQ# 61 Parkinson disease Alzheimer disease 61 Omacetaxine 61 induce remission 61 Valproic acid 61 Signaling Pathway 61 cytotoxic therapies 61 tPA antithrombotics anticoagulation therapy 61 advanced metastatic renal 61 somatostatin analog 61 hormone LHRH antagonist 61 rALLy clinical trial 61 SNT-MC#/idebenone 61 hematologic diseases 61 Commonly prescribed 61 RhuDex 61 JAK inhibitors 61 erlotinib Tarceva ® 61 vinorelbine tartrate 61 occlusion PAO 61 targeted radiotherapeutic 61 nilotinib Tasigna ® 61 alpha#beta# integrin 61 progressive neurodegenerative disorder 61 Tyrima 61 polyneuropathy HIV DSP 61 Prodarsan 61 imatinib Gleevec ® 61 neovascular age 61 ATL# [001] 61 Cloretazine R 61 metastatic androgen independent 61 ® bortezomib 61 vaso occlusive crisis 61 neuromuscular spasm 61 commercialize deforolimus 61 Treatment Reduces 61 5 HT2A serotonin 61 Factor VIIa 61 5 HT6 receptor 61 oral Janus kinase 61 lymphomas leukemias 61 Chronic lymphocytic leukemia 61 R#/MEM # 61 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 61 ADVEXIN p# therapy 61 antiangiogenic agent 61 Initiates Enrollment 61 P#X# 61 rheumatoid arthritis lupus 61 damage cirrhosis liver 61 Hsp# Inhibitor 61 diseases fat malabsorption 61 Wnt signaling pathway 61 hypoxia activated prodrug 61 endocrinology orthopedics kidney 61 selective modulator 61 brand ciclesonide HFA 61 Systemic lupus erythematosus 61 Crofelemer budesonide foam 61 Idiopathic pulmonary fibrosis 61 chemoattractant receptors 61 Parkinson disease monogenic diseases 61 Current Lm vaccines 61 OMP #R# 61 autoimmune uveitis 61 inflammation metabolic disorders 61 bladder ovarian 61 Pirfenidone 61 SinuNase ™ 61 EGFR HER 61 therapeutic monoclonal antibodies 61 evaluate ZFP Therapeutic 61 Herceptin monoclonal antibody 61 multiple sclerosis inflammatory bowel 61 LymphoStat B TM 61 indolent follicular non 61 Gamunex C 61 inflammation thrombosis oncology 61 Arranon 61 Study Shows Promise 61 filter cytokines 61 Strep Staph 61 sulfonylhydrazine class 61 inflammation autoimmune diseases 61 degenerative neurological diseases 61 Dasatinib 61 Removab 61 Fx #A 61 mTOR inhibitors 61 immuno modulatory 61 renal failure interstitial lung 61 FOLOTYN ® 61 CCR1 61 mitoxantrone plus 61 Bucindolol 61 neuropathic pain nerve 61 resistant hormone refractory 61 psychiatric disorders ATI 61 ovarian breast 61 collagen vascular 61 Della Reese Stronger Than 61 mRNA antagonist 61 riociguat 61 OMP #M# 61 infectious diseases autoimmune diseases 61 retinopathy nephropathy 61 Panzem R 61 endocrine therapies 61 Cancer cachexia 61 polycythemia vera essential thrombocythemia 61 JAK2 enzyme 61 antibody MAb 61 motesanib 61 selective kinase inhibitor 61 PROCRIT ® 61 PROSTVAC VF 61 BY DAVID CRIGGER 61 antimetabolites 61 P#X# receptors 61 smallpox SIGA 61 taxane chemotherapy administered 61 de novo kidney transplant 61 #beta HSD1 61 radiation chemoradiation 61 trauma malignant tumors 61 biologic pathways 61 Cethrin R 61 chronic thromboembolic pulmonary 61 novel peptide 61 immunomodulatory therapy 61 toenail onychomycosis 61 plus prednisone prednisolone 61 pediatric malignancies 61 Nerve Targeting Drug 61 Avandia Actos 61 Menopausal hormone therapy 61 Syndax Pharmaceuticals Inc. 61 hematological diseases 61 Novel Oral 61 PI3K/Akt pathway inhibitor 61 Survival Protein modulation 61 MediGene focuses 61 Provecta TM 61 PKC# 61 histone deacetylase inhibitors 61 Aviptadil 61 DCVax R 61 Healthbeat Report 61 hypereosinophilic syndrome 61 HER2 positivity 61 engineered proteases 61 complement inhibitor eculizumab 61 Symadex 61 IgG1 monoclonal antibody 61 Telik logo TELINTRA 61 bardoxolone methyl 61 diagnostic biomarkers 61 myelin protective sheath 61 benign prostatic hyperplasia enlarged 61 TTR gene 61 Glucocorticoid 61 thalidomide Thalomid 61 Leukemia lymphoma 61 virally induced 61 DEB# 61 mutated BRAF gene 61 lintuzumab SGN 61 receiving XGEVA 61 KRAS oncogene 61 Resurgex Plus R 61 ADVEXIN therapy 61 novel peptides 61 TNF Tumor Necrosis Factor 61 detect amyloid plaque 61 TLR7 agonist 61 bone spurs bulging 61 Intravenous CP 61 MGd 61 stent neointimal growth 61 Curaxin 61 pemphigus vulgaris 61 fibrosis oncology 61 osteoclast activity 61 peptidic compound 61 Ceflatonin 61 denileukin diftitox 61 lupus hepatitis C 61 oxypurinol 61 idiopathic thrombocytopenic purpura ITP 61 personalized cellular immunotherapy 61 refractory indolent non 61 Aplidin R 61 CCR5 receptor antagonist 61 MKC# MKC# PP 61 MTP inhibitor 61 Ketotransdel TM 61 advanced malignant hepatic 61 constipation predominant irritable bowel 61 PEG SN# 61 Complicated Skin 61 Synta Announces 61 metastatic gastric 61 protein RAP 61 balloon hem minidresses 61 CCX# 61 read Palintologist 61 arthritis PsA 61 Thoratec Schedules 61 huC# DM4 61 decompensated liver disease 61 biliary tract cancer 61 CD8 + cytotoxic 61 IMC #B 61 Phase 1b clinical trials 61 cisplatin resistant 61 HCD# [002] 61 antiproliferative effects 61 refractory prostate cancer 61 oral FTY# 61 imexon 61 endosomal release 61 childbearing age mirrors 61 AEG# 61 synthetic cannabinoid compounds 60 IgG1 antibody 60 chronic inflammations 60 cannabinor 60 Ceflatonin R 60 candidate SMaRT Replacement 60 Epothilones 60 TRPV1 agonist 60 relapsed leukemia 60 Zemplar Capsules 60 CRLX# 60 Campath alemtuzumab 60 Phase Ib IIa 60 MyVax R 60 novel emulsion formulation 60 Davunetide 60 radionuclide therapy 60 Chronic HCV 60 Lewy bodies DLB 60 hereditary degenerative 60 Slow Progression 60 Cabazitaxel 60 midstage trials 60 liver colon rectal 60 Anticonvulsant 60 cause cardiac channelopathies 60 VA# [002] 60 DVT prophylaxis cholesterol 60 Vincristine 60 Acoustic Neuroma 60 RNAi therapeutic targeting 60 Cotara ® 60 Alzheimer disease dyslipidemia 60 BRAF inhibitors 60 By SALLY SPAULDING 60 LHON 60 systemic juvenile idiopathic 60 Idiopathic pulmonary fibrosis IPF 60 Anthrax Toxin 60 Bafetinib 60 inflamed scaly red 60 TRANSDUR ® 60 diarrhea predominant irritable 60 Insegia 60 Liprotamase 60 CB2 receptor 60 immuno compromised individuals 60 Cutaneous T 60 evaluating tivozanib 60 By JENNIFER KOVACS 60 cilengitide 60 Bronchopulmonary Dysplasia 60 protein tyrosine phosphatases 60 alpha1 antitrypsin deficiency 60 P#X# antagonist 60 BCG refractory carcinoma 60 potent anti angiogenic 60 anaphylactic reactions bronchospasm 60 c MET 60 genetic lysosomal storage 60 malignant ascites 60 Tykerb lapatinib 60 OTCBB URGP specialty 60 oral talactoferrin 60 ALN HTT 60 recurrent glioma 60 therapies ACTs 60 corticosteroid dexamethasone 60 Endotoxin Activity Assay 60 hypertension hypercholesterolemia 60 CD4 monoclonal antibody 60 Phase 2b Clinical Trial 60 BENLYSTA TM 60 Romiplostim 60 Investigational Treatment 60 Postherpetic neuralgia PHN 60 By Beth Sneller 60 proprietary polysaccharide 60 vidofludimus 60 oral JAK#/JAK# inhibitor 60 cyclin dependent kinases 60 CYT# novel 60 systemic invasive fungal 60 ACTEMRA TM 60 relieve bronchial spasms 60 cortisol synthesis 60 lesser extent polymetallic 60 investigational antibody 60 ALK inhibitors 60 abnormal p# 60 dyskeratosis congenita 60 HCV NS5B polymerase 60 recurrent glioblastoma multiforme GBM 60 convulsive anti depressant 60 ovarian bladder 60 pediatric neuroblastoma 60 ZFP TF 60 synthetic cannabinoid library 60 Relapsing remitting MS 60 nucleoside analog 60 sd rxRNA 60 deCODE BreastCancer 60 antiangiogenesis 60 Syncria albiglutide 60 MTDH 60 etanercept Enbrel 60 number NCT# ClinicalTrials.gov 60 Philadelphia Chromosome Positive 60 destroys myelin 60 used DNA alkylating 60 lymphotoxin 60 TBC M4 60 Dupuytren Disease 60 enhance ApoA 60 p# biomarker 60 ovarian colon 60 reliably caucused 60 lumiliximab 60 baminercept 60 primary immunodeficiency PI 60 immuno inflammatory diseases 60 Photodynamic therapy PDT 60 Temodar ® 60 selectively induce apoptosis 60 Virus Linked 60 PORxin TM 60 TRIOLEX HE# 60 Crohns disease 60 Vidaza azacitidine 60 Bone Marrow Transplants 60 GLPG# 60 histone deacetylase HDAC 60 Aryplase 60 Glaxo Tykerb 60 cognitive impairment associated 60 Meets Primary Endpoint 60 CR# vcMMAE 60 hour bronchodilation 60 infliximab Remicade 60 ELADUR ™ 60 pragmatic reengineering 60 hematological cancers notably 60 Plaquenil 60 photodynamic treatment 60 fungal infections Hepatitis C 60 semi synthetic lipoglycopeptide 60 monoclonal antibody IgG1 Mab 60 commercialize CorMedix drug 60 anti angiogenic agent 60 infectious autoimmune 60 regulate therapeutically important 60 Unigene nasal calcitonin 60 ceroid lipofuscinosis NCL 60 hepatitis C lupus 60 oligodendrocyte progenitor cells 60 cerebro cardiovascular diseases 60 Nanobody ® 60 Empatic ™ 60 TGF beta pathway 60 Tyrosine Kinase Inhibitor 60 approved incretin mimetic 60 velafermin 60 Lupus Nephritis 60 Levels Linked 60 Eliezer Zomer Ph.D. 60 Fibromyalgia Syndrome 60 Gene Linked 60 vitreous floaters 60 Clot busting 60 eIF 4E 60 HER2 Positive Breast Cancer 60 Idiopathic Thrombocytopenic Purpura ITP 60 HDAC Inhibitor 60 Associated Adipose Redistribution 60 SomatoKine 60 Mitoxantrone 60 investigational humanized monoclonal antibody 60 Tumour Vascular Disrupting Agent 60 PNT# 60 nicotinic acetylcholine receptor 60 validating biomarkers 60 HPV cervical dysplasia 60 HuCNS SC ® 60 induced mucositis 60 Bavituximab 60 Olaparib 60 Enkephalin 60 Nasdaq HALO biopharmaceutical 60 Shortened telomeres 60 brivaracetam 60 XL# anticancer compounds 60 histologically active 60 histone deacetylase HDAC inhibitor 60 JAK2 Inhibitor 60 chronic renal disease 60 nociceptive pain 60 Annamycin 60 B Raf V#E 60 progressive metastatic prostate 60 Vitrasert R 60 Cloretazine 60 Ii protein 60 post herpetic